National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing, China.
Division of Communicable Diseases, World Health Orgnization China Office, Beijing, China.
BMJ Open. 2018 Oct 25;8(10):e020717. doi: 10.1136/bmjopen-2017-020717.
To assess the feasibility and acceptability of using WHO prequalified combined dual HIV/syphilis rapid diagnostic tests (RDT) for same-day results in antenatal care (ANC) clinics.
This is a pragmatic implementation study using quantitative approach to evaluate outcomes. Antenatal clinic attendees from 21 rural and urban township hospitals in two provinces of China were offered with free dual RDTs testing that included HIV and syphilis, in addition to the routine blood tests. Study outcomes included testing uptake before and during dual RDT use, test feasibility and acceptability among pregnant women. Regression model was used to assess acceptance of RDT testing.
In total, 1787 out of 1828 pregnant women attending ANC received the RDT testing. Testing uptake among pregnant women in their first and second trimester increased from 76.0% (2438/3269) using standard blood testing to 90.1% (1626/1787) with concurrent RDT use (χ=197.1, p<0.001). Among 1787 pregnant women who received RDT tests, 98.3% (1757/1787) participants were given test result the same day. Positive proportions of HIV and syphilis screened with RDT were 0.06% (1/1787) and 1.0% (18/1787), respectively. Regression analysis indicated that women who did not receive syphilis or HIV testing before were less likely to accept dual RDT (OR 0.28, 95% CI 0.10 to 0.75). Acceptance for dual RDT testing at second or third antenatal visit was lower compared with the first visit (OR 0.37, 95% CI 0.15 to 0.94).
Combined dual HIV/syphilis RDT with same-day results increased uptake of HIV and syphilis testing among pregnant women at primary healthcare facilities. Given the diversity of testing capacities among health services especially in rural areas in China, the dual RDT kit is feasible tool to improve testing uptake among pregnant women.
评估在产前保健(ANC)诊所使用世界卫生组织(WHO)预认证的联合 HIV/梅毒快速诊断检测(RDT)进行当日结果检测的可行性和可接受性。
这是一项采用定量方法评估结果的实用实施研究。中国两个省份的 21 个农村和城市乡镇医院的 ANC 就诊者除了接受常规血液检测外,还提供免费的双重 RDT 检测,包括 HIV 和梅毒。研究结果包括在使用双重 RDT 之前和期间的检测接受率、孕妇的检测可行性和可接受性。采用回归模型评估 RDT 检测的接受率。
共有 1787 名接受 ANC 的孕妇接受了 RDT 检测。在使用标准血液检测时,孕妇在第一和第二孕期的检测接受率从 76.0%(2438/3269)增加到使用 RDT 时的 90.1%(1626/1787)(χ=197.1,p<0.001)。在接受 RDT 检测的 1787 名孕妇中,98.3%(1757/1787)的孕妇当天获得了检测结果。RDT 筛查的 HIV 和梅毒阳性率分别为 0.06%(1/1787)和 1.0%(18/1787)。回归分析表明,以前未接受梅毒或 HIV 检测的女性不太可能接受双重 RDT(OR 0.28,95%CI 0.10 至 0.75)。与第一次就诊相比,第二次或第三次 ANC 就诊时接受双重 RDT 检测的可能性较低(OR 0.37,95%CI 0.15 至 0.94)。
在初级医疗保健机构中,具有当日结果的联合 HIV/梅毒双重 RDT 提高了孕妇对 HIV 和梅毒检测的接受率。考虑到中国卫生服务机构的检测能力存在差异,特别是在农村地区,双重 RDT 试剂盒是提高孕妇检测接受率的可行工具。